Back to search
FDAFDA · Food and drugs·Recall number D-0633-2024

Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01

Published August 21, 2024 · Recall initiated: August 7, 2024

Summary

FDA records drug Class III recall D-0633-2024, published August 21, 2024 and initiated August 7, 2024. Recalling firm: Taro Pharmaceuticals U.S.A., Inc.; Status: Completed; Reported quantity: 96 vials; Lot: Lot # AD12890, Exp 09/30/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Taro Pharmaceuticals U.S.A., Inc.
Distributor
Product was distributed to one distributor
Lot
Lot # AD12890, Exp 09/30/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01 recalled?

Yes. FDA published recall D-0633-2024 on August 21, 2024. Reported hazard: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter